Expression of interleukin-13 receptor α 1-subunit on peripheral blood eosinophils is regelated by cytokines

Immunology

Volumn 112, Issue 4, 2004, Pages 597-604

  Myrtek, Daniel ^a,b   Knoll, Mathias ^a   Matthiesen, Timm ^a   Krause, Sebastian ^b,c   Lohrmann, Jens ^d   Schillinger, Dirk ^d   Idzko, Marco ^a   Virchow, J Christian ^e   Friedrich, Karlheinz ^c   Luttmann, Werner ^e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF OLDENBURG   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d Genovac   (Germany)

^e ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Asthma; IL 13 receptor; Surface expression; Transforming growth factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; RECEPTOR SUBUNIT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALPHA CHAIN; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FLOW CYTOMETRY; GENE EXPRESSION; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; EOSINOPHILS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; MONOCYTES; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 4043050048     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2004.01897.x     Document Type: Article

References (42)

1. Minty A, Chalon P, Derocq JM et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-50.
2. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19-26.
3. de Vries JE. Molecular and biological characteristics of interleukin-13. Chem Immunol 1996; 63:204-18.
4. Marsh DG, Neely JD, Breazeale DR et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994; 264:1152-6.
5. Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 2003; 111:677-90.
6. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-61.
7. Grunig G, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282:2261-3.
8. Wills-Karp M, Chiaramonte M. interleukin-13 in asthma. Curr Opin Pulm Med 2003; 9:21-7.
9. Luttmann W, Knoechel B, Foerster M, Matthys H, Virchow JC Jr, Kroegel C. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J Immunol 1996; 157:1678-83.
10. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995; 154:799-803.
11. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103:779-88.
12. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, Foster PS, Rothenberg ME. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001; 108:594-01.
13. Schmid-Grendelmeier P, Altznauer F, Fischer B et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002; 169:1021-7.
14. Lin JX, Migone TS, Tsang M et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995; 2:331-9.
15. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 1996; 271:29265-70.
16. Gauchat JF, Schlagenhauf E, Feng NP et al. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur J Immunol 1997; 27:971-8.
17. Callard RE, Matthews DJ, Hibbert L. IL-4 and IL-13 receptors: are they one and the same? Immunol Today 1996; 17:108-10.
18. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P. Cloning and characterization of a specific interleukin (IL) -13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 1996; 271:16921-6.
19. Donaldson DD, Whitters MJ, Fitz LJ et al. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 1998; 161:2317-24.
20. Zhang JG, Hilton DJ, Willson TA et al. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor alpha-chains. J Biol Chem 1997; 272:9474-80.
21. Luttmann W, Matthiesen T, Matthys H, Virchow JC Jr. Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-alpha on eosinophil activation in vitro. Am J Respir Cell Mol Biol 1999; 20:474-80.
22. Hellman C, Hallden G, Hylander B, Lundahl J. Regulation of the interleukin-5 receptor alpha-subunit on peripheral blood eosinophils from healthy subjects. Clin Exp Immunol 2003; 131:75-81.
23. Gregory B, Kirchem A, Phipps S, Gevaert P, Pridgeon C, Rankin SM, Robinson DS. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines. IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression. J Immunol 2003; 170:5359-66.
24. Zheng T, Zhu Z, Liu W, Lee CG, Chen Q, Homer RJ, Elias JA. Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro. J Allergy Clin Immunol 2003; 111:720-8.
25. Hartnell A, Robinson DS, Kay AB, Wardlaw AJ. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 1993; 80:281-6.
26. Luttmann W, Opfer A, Dauer E et al. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils. Eur J Immunol 1998; 28:2057-65.
27. Wedi B, Raap U, Lewrick H, Kapp A. IL-4-induced apoptosis in peripheral blood eosinophils. J Allergy Clin Immunol 1998; 102:1013-20.
28. Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356:152-4.
29. Thompson J, Lang S. Genetic immunization for antibody production. Tutorial: GENOVAC's technological shortcut from gene to antibody. Genet Eng News 2002; 22:62-3.
30. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science 1990; 247:1465-8.
31. Luttmann W, Dauer E, Schmidt S, Marx O, Hossfeld M, Matthys H, Virchow JC Jr. Effects of interferon-gamma and tumour necrosis factor-alpha on CD95/Fas ligand-medialed apoptosis in human blood eosinophils. Scand J Immunol 2000; 51:54-9.
32. Kimura I, Moritani Y, Tanizaki Y. Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy 1973; 3:195-02.
33. Luttmann W, Franz P, Schmidt S, Barth J, Matthys H, Virchow JC Jr. Inhibition of HLA-DR expression on activated human blood eosinophils by transforming growth factor-beta1. Scand J Immunol 1998; 48:667-71.
34. Liu LY, Sedgwick JB, Bates ME et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils. II. IL-5 down-modulates its receptor via a proteinase-mediated process. J Immunol 2002; 169:6459-66.
35. Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991; 251:313-16.
36. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163:1037-50.
37. Wahl SM, Hunt DA, Wong HL et al. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 1988; 140:3026-32.
38. Alam R, Forsythe P, Stafford S, Fukuda Y. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 1994; 179:1041-5.
39. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63:515-24.
40. Iwamoto I, Nakajima H, Endo H, Yoshida S. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993; 177:573-6.
41. Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993; 148:1102-4.
42. Valerius T, Repp R, Kalden JR, Platzer E. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol 1990; 145:2950-8.